Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jae Hyeon Park has a total of 127 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic contribution of anaerobic bottles in pediatric blood cultures: experience at a tertiary children’s hospital

    by Ju Hyeong Lee, Baek Sup Shin, Taek Soo Kim, Sue Shin, Ki Wook Yun, Eun Hwa Choi, Jae Hyeon Park

    Routine use of anaerobic bottles in pediatric blood cultures remains controversial because diagnostic yield must be balanced against limited sampling volume. We retrospectively analyzed paired pediatric aerobic–anaerobic blood cultures collected from patients younger than 18 years at a tertiary children’s hospital from January 2020 through December 2024. Accession-defined paired sets received within 15 min were grouped into culture episodes; episodes containing at least two paired sets comprised the primary cohort. Among 24,485 multi-set episodes from 8,658 patients, 999 (4.1%) were positive, and 387 (1.6%) were potential-contaminant episodes. Confirmed anaerobic-bottle contribution was observed in 208 positive episodes (20.8%), comprising additional organism recovery in 159 (15.9%) and detection more than 4 h earlier in 49 (4.9%); the absolute added yield was 8.5 per 1,000 episodes. Obligate anaerobes were identified in 11 positive episodes, whereas the majority of the contribution came from facultative organisms, particularly Staphylococcus aureus , Escherichia coli , and viridans group streptococci. Contribution was highest in the emergency room (28.2%) and neonatal intensive care unit (25.0%). Compared with the general ward, adjusted odds were higher in the emergency room (adjusted odds ratio, 1.83; 95% confidence interval, 1.23 to 2.73) and lower in the hemato-oncology ward (0.43; 0.21 to 0.85). Contribution was 21.8% among children younger than 4 years. The overall median within-accession time-to-positivity difference (anaerobic minus Peds Plus/F) was small (−0.17 h), although selected organisms showed earlier anaerobic detection. Anaerobic bottles provided complementary diagnostic information in approximately one-fifth of positive pediatric blood culture episodes, mainly through additional recovery rather than uniformly earlier detection. IMPORTANCE: Children often have only a small amount of blood available for culture, making the choice of culture bottles important. In this hospital-wide study, anaerobic bottles added diagnostic information in about one-fifth of positive pediatric blood culture episodes, mainly by recovering organisms that were not found in the paired pediatric aerobic bottle. Most of this benefit involved common bloodstream pathogens that can grow with or without oxygen, including Staphylococcus aureus and Escherichia coli , rather than rare obligate anaerobes. A similar overall contribution proportion was observed among children younger than 4 years. However, the pediatric aerobic bottle recovered more organisms overall in direct paired comparisons. These findings support viewing the two bottle types as complementary and emphasize that pediatric blood culture practice should balance adequate total blood volume with thoughtful allocation between bottle types.

  • Open Access

    Whole-genome characterization of Candidozyma auris isolates from a Korean tertiary care centre: clade II predominance, partly unexplained fluconazole resistance and a clade I isolate

    by Jae Hyeon Park, Jee-Soo Lee, Seung Won Chae, Taek Soo Kim, Moon-Woo Seong

    In South Korea, Candidozyma auris is dominated by ear-associated clade II isolates, but institution-based genomic data remain limited. We analysed 35 archived isolates from 29 patients at a tertiary care centre between 2017 and 2023 using antifungal susceptibility testing and whole-genome sequencing. Thirty-four isolates belonged to clade II, and one urine isolate recovered after inter-hospital transfer belonged to subclade Ib. Serial clade II isolates from the same patient clustered together and had lower pairwise SNP distances than different-patient pairs (median, 8.5 versus 181). Among the first isolates from 29 patients, 14 (48.3%) were fluconazole resistant. In first clade II isolates, recurrent curated coding variation was concentrated in TAC1B and ERG11 ; TAC1B F214S and W198C and ERG11 K143R occurred only in resistant isolates, but recognized coding variants did not account for all resistant isolates. Clade II isolates shared a broadly conserved subtelomeric deletion backbone, with variable chromosome 6 loss of selected glycosylphosphatidylinositol-anchor genes. The clade Ib isolate carried ERG11 Y132F, TAC1B A583S and a CDR1 V704L/E709D-like change and met CDC tentative breakpoints for resistance to fluconazole, amphotericin B and caspofungin. These findings refine the genomic profile of Korean clade II isolates and highlight the potential introduction of a distinct clade I lineage through healthcare transfer.

  • Open Access

    Pretransfusion testing interference profile of IMC ‐002: A novel anti‐ CD47 monoclonal antibody engineered for minimized red cell binding

    by Tae‐Shin Kim, Jae Hyeon Park, Yousun Chung, Dae‐Hyun Ko, Seon Young Kim, Hyungsuk Kim

    Background: CD47‐targeted agents can interfere with pretransfusion testing due to CD47 expression on red blood cells (RBCs). IMC‐002 is a novel anti‐CD47 human IgG4 monoclonal antibody engineered to minimize RBC binding; however, its interference profile during pretransfusion testing remains poorly characterized. Study Design and Methods: Whole blood samples were incubated with IMC‐002 and tested by tube, gel card, and automated methods for ABO/RhD typing, direct antiglobulin test (DAT), and RBC phenotyping. Plasma spiked with IMC‐002 underwent antibody screening by tube and gel methods, adsorption studies, and carryover assessment. Flow cytometry compared IMC‐002 binding between RBCs and T cells. Results: IMC‐002 interfered with ABO/RhD typing, DAT, and antibody screening, but the extent varied by assay. Forward grouping interference was mitigated by saline washing. In contrast, reverse grouping interference was most prominent in gel cards but was resolved in tube testing via saline replacement. Antibody screening showed panreactive false‐positive results, which were stronger in gel cards and with papain‐treated RBCs. However, the magnitude of interference was lower than that reported for other CD47‐targeted agents. Flow cytometry confirmed minimal IMC‐002 binding to RBCs compared to dose‐dependent binding to CD3+ T cells. Conclusions: IMC‐002 exhibits a distinct pretransfusion interference profile compared with previously reported CD47‐targeted agents. Its interference appears partly mitigable by routine laboratory measures and is consistent with its engineered low RBC affinity, underscoring the need for agent‐specific evaluation of CD47‐targeted therapeutics in transfusion practice.

  • Open Access

    Weissella viridescens Bacteremia Associated with Acute Cholangitis: a Case Report

    by Jiwoo Lee, Jee-Soo Lee, Taek Soo Kim, Hyunwoong Park, Moon-Woo Seong, Sue Shin, Jae Hyeon Park

    Jiwoo Lee, M.D., Jee-Soo Lee, M.D., Ph.D., Taek Soo Kim, M.D., Hyunwoong Park, M.D., Ph.D., Moon-Woo Seong, M.D., Ph.D., Sue Shin, M.D., Ph.D., and Jae Hyeon Park, M.D., Ph.D.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2025.0749

  • Open Access

    Diagnostic performance evaluation of the PowerChek Respiratory Virus Panels 1, 2, 3, and 4 for the detection of respiratory viruses, including SARS-CoV-2

    by Kyeong Seon Ryu, Jae Hyeon Park, Jee-Soo Lee, Moon-Woo Seong

    Background: The accurate laboratory-based detection of respiratory viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is essential for effective patient management and infection control in the post–coronavirus disease 2019 era. In this study, the performance of the PowerChek Respiratory Virus Panels 1–4 assay (Kogene Biotech) in detecting non-SARS-CoV-2 respiratory viruses and SARS-CoV-2 was compared with those of two established commercial assays. Methods: Residual clinical respiratory specimens collected between December 2023 and February 2024 were retested using the PowerChek assay. Of the 129 specimens retested, 80 had tested positive for 14 non-SARS-CoV-2 respiratory virus targets in the Allplex Respiratory Panels 1–3 assay (Seegene) and 49 had been tested using the Alinity m SARS-CoV-2 assay (Abbott; 20 positive and 29 negative for SARS-CoV-2). Agreement, Cohen’s kappa, and discordant results were assessed. Results: For the 14 non-SARS-CoV-2 respiratory virus targets, the virus-specific overall percent agreement (OPA) ranged from 95.0% to 100%, the positive percent agreement (PPA) ranged from 66.7% to 100%, and the negative percent agreement (NPA) ranged from 96.0% to 100%, with kappa values of 0.64–1.00. Lower agreements were observed for human coronavirus OC43 and influenza A virus. For SARS-CoV-2 detection, the OPA was 98.0% (PPA, 95.0%; NPA, 100%; kappa, 0.96). Conclusion: The detection performance of the PowerChek assay was comparable to those of the established assays for most respiratory virus targets, with lower agreement observed for some targets. These features support its practical utility for the routine multiplex molecular detection of respiratory viruses, including SARS-CoV-2.

  • Open Access

    Pulmonary infection caused by Segniliparus rugosus in a patient without systemic immunodeficiency but with bronchiectasis: f irst identification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry with whole-genome confirmation

    by Jaesoon Kim, Nakwon Kwak, Jee-Soo Lee, Taek Soo Kim, Moon-Woo Seong, Jae Hyeon Park

    Segniliparus spp. are acid-fast, rapidly growing bacteria associated with pulmonary infections, particularly in patients with underlying lung disease. Two species, Segniliparus rugosus and Segniliparus rotundus, were f irst reported in 2005 from unidentifiable mycobacterial samples suspected of being involved in respiratory mycobacteriosis [1]. Segniliparus spp. infection in humans is exceedingly rare. To date, eight cases have been reported worldwide, with most having been caused by S. rugosus in patients with cystic fibrosis or bronchiectasis [2–7]. In previous reports, species identification relied primarily on 16S rRNA gene sequencing and less frequently on rpoB gene sequencing. Here, we present a case of pulmonary S. rugosus infection in a patient without evidence of systemic immunodeficiency but with bronchiectasis and prior nontuberculous mycobacterial pulmonary disease (NTM-PD), identified for the first time by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and confirmed by wholegenome sequencing (WGS). This case highlights that MALDI-TOF MS can identify rare acid-fast organisms within routine clinical workflows, with WGS providing species-level confirmation.

  • Open Access

    First Report of Concurrent Infective Endocarditis and Spondylitis Caused by Lactococcus petauri

    by Kyeong Seon Ryu, Taek Soo Kim, Sue Shin, Jae Hyeon Park

    Kyeong Seon Ryu, M.D., Taek Soo Kim, M.D., Sue Shin, M.D., Ph.D., and Jae Hyeon Park, M.D., Ph.D.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2025.0592


  • Open Access

    A Nationwide Study on Pretransfusion Testing for 10 Years in Korea Using Health Insurance Review and Assessment Claims Data

    by Jae Hyeon Park, Yousun Chung, Dae-Hyun Ko, Hyungsuk Kim

    Park JH, et al. J Korean Med Sci. 2026 Jun;41(23):e162. https://doi.org/10.3346/jkms.2026.41.e162

  • Open Access

    Bacteremia Caused by a Putative Novel Species in the Genus Erwinia: A Case Report and Genomic Analysis

    by Jiwoo Lee, Taek Soo Kim, Hyunwoong Park, Jae Hyeon Park

    We report a case of catheter-associated bloodstream infection caused by a putative novel species in the genus Erwinia, identified using whole-genome sequencing (WGS). A female adolescent receiving long-term home parenteral nutrition via a central venous catheter (CVC) presented with a fever. Gram-negative rods were isolated from two CVC-derived blood culture sets, while peripheral cultures remained negative. Conventional identification methods, including VITEK 2, Phoenix M50, MALDI-TOF MS, and 16S rRNA and rpoB gene sequencing, failed to achieve species-level identification. WGS was performed on the isolate using Illumina MiSeq. Genomic analysis revealed a genome size of 5.39 Mb with 56.8% GC content and high assembly completeness. The highest average nucleotide identity (ANI) was 90.3% with Pantoea coffeiphila, and ≤85% with known Erwinia species, suggesting that it represents a distinct taxon. Phylogenetic analyses placed the isolate within the Erwinia clade but separate from any known species. Antimicrobial susceptibility testing showed broad susceptibility. This case highlights the utility of WGS for the identification of rare or novel organisms not captured by conventional methods and expands the clinical spectrum of Erwinia species. While the criteria for species delineation were met, the phenotypic characterization remains insufficient to formally propose a new species.


  • Open Access

    New-Onset Type 1 and Type 2 Diabetes Among Korean Youths During the COVID-19 Pandemic

    by Da Hye Lee, Hwa Young Kim, Ji Young Park, Jaehyun Kim, Jae Hyeon Park

    Importance: Whether COVID-19 contributes to youth-onset diabetes is controversial, and research in Asia is lacking.Objective: To explore the incidence and severity of diabetes among youths during the COVID-19 pandemic in South Korea.Design, Setting, and Participants: This cohort study used claims data for January 1, 2017, through February 28, 2022, from the National Health Insurance Service database in South Korea. The incidence of type 1 diabetes (T1D) and type 2 diabetes (T2D) in patients younger than 20 years during the pandemic was analyzed and compared with that during the prepandemic period. The study included incident cases of T1D identified by at least 2 diagnosis codes with at least 2 insulin prescriptions within 1 year and T2D identified by at least 2 diagnosis codes with at least 2 prescriptions of diabetes medication within 1 year. Analyses were performed between January 29 and September 2, 2024.Exposures: COVID-19 pandemic and SARS-CoV-2 infection.Main Outcomes and Measures: The primary outcome was incidence of T1D and T2D, and secondary outcomes included the rate of diabetic ketoacidosis (DKA) and association of new-onset diabetes with SARS-CoV-2 positivity.Results: The study included 2599 patients with T1D (mean [SD] age, 12.0 [4.8] years; 1235 [47.5%] male) and 11 040 patients with T2D (mean [SD] age, 16.0 [2.8] years; 6861 [62.1%] male). During the pandemic, the incidence rate ratios were 1.19 (95% CI, 1.10-1.29) for T1D and 1.41 (95% CI, 1.36-1.46) for T2D. The incidence rate of DKA at diagnosis increased during the first pandemic year compared with the prepandemic period (T1D, 42.8% [95% CI, 38.5%-47.0%] vs 31.3% [95% CI, 29.0%-33.7%], respectively; T2D, 6.0% [95% CI, 5.0%-7.1%] vs 2.9% [95% CI, 2.5%-3.3%], respectively) but returned to prepandemic levels in the second pandemic year (T1D, 34.5% [95% CI, 30.6%-38.5%]; T2D, 3.2% [95% CI, 2.6%-3.9%]). The hazard ratio for new-onset diabetes associated with SARS-CoV-2 positivity was 0.44 (95% CI, 0.17-1.13) for T1D and 1.08 (95% CI, 0.74-1.57) for T2D.Conclusions and Relevance: These findings suggest that the incidence and severity of T1D and T2D among South Korean youths increased during the COVID-19 pandemic. The cohort analysis does not support SARS-CoV-2 infection itself as being directly associated with incident diabetes.